LISA DEGEN: Open Payments
NPI 1639308893 · GRAND ISLAND, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 42 payments from 8 companies in 2025. Trend: 2023 $495 · 2024 $473 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $205 |
| Abbott Laboratories | 3 | $72 |
| Novo Nordisk Inc | 3 | $50 |
| Madrigal Pharmaceuticals | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 5 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: VRAYLAR, FREESTYLE LIBRE 3, QULIPTA, UBRELVY, REZDIFFRA, REXULTI, Rybelsus, VOQUEZNA.
Industry payments across NE — which companies pay providers there.
